HEMATOLOGIC MALIGNANCIES
Clinical trials for HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lower-Dose transplant drug aims to tame side effects in blood cancer fight
Disease control Not yet recruitingThis study is testing if a lower dose of a drug called cyclophosphamide, given after a stem cell transplant, can safely prevent a serious complication called graft-versus-host disease (GVHD) while still helping control blood cancers. It will involve 41 adults with various blood c…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for elderly blood cancer patients with experimental transplant prep
Disease control Not yet recruitingThis study is testing a specific combination of chemotherapy drugs given before a cord blood transplant for patients aged 60-69 with blood cancers. The goal is to see if this new preparatory regimen is safe and effective at helping the transplant succeed while controlling the can…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
First human test for new hope against tough blood cancers
Disease control Not yet recruitingThis is a first-in-human study to test the safety and initial effects of a new drug called BL-M24D1. It is for adults with advanced multiple myeloma or other blood cancers that have come back or stopped responding to standard treatments. The main goals are to find a safe dose and…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Early trial tests 'Ready-Made' cell therapy for tough blood cancers
Disease control Not yet recruitingThis is an early safety study testing a new type of cell therapy for adults with B-cell blood cancers that have returned or not responded to standard treatments. The therapy, called 19UCART, uses genetically modified immune cells from a donor (not the patient) to target and kill …
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: YANRU WANG • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC